Gabor G. Kovacs

Key facts

• His Tanz Centre faculty page and the University of Toronto Laboratory Medicine and Pathobiology faculty page both list him as Professor in that department, consultant neuropathologist in the Laboratory Medicine Program at University Health Network, principal investigator at the Tanz Centre for Research in Neurodegenerative Disease, senior scientist at the Krembil Brain Institute, faculty in the Edmond J. Safra Program in Parkinson's Disease and co-director of the Rossy Program for Progressive Supranuclear Palsy Research.
• The Tanz Centre profile page and the UHN Research profile add that he holds the Rossy Chair in PSP research at UHN and acts as consultant neurologist in the UHN movement disorders clinic.
• His ORCID employment record dates all four Toronto posts from 1 May 2019 with no end date entered, and dates his Medical University of Vienna associate professorship from 1 August 2007 to 30 April 2019.
• The same record lists an earlier Vienna period, residency in neuropathology at the Institute of Neurology from May 2000 to June 2002, so his Vienna connection predates the professorship by seven years.
• The Tanz Centre profile page and the UHN profile state that he led the Hungarian Reference Center for Human Prion Diseases from 2004 to 2019 and the Austrian Reference Center for Human Prion Diseases from 2011 to 2019; the Laboratory Medicine and Pathobiology page gives 2007 to 2019 for the Hungarian centre and the same 2011 to 2019 for the Austrian one.
• He was head of the Department of Neuropathology at the National Institute of Psychiatry and Neurology in Budapest; the Toronto profiles date this 2004 to 2007 and his ORCID record dates it January 2003 to July 2007.
• He trained at Semmelweis University in Budapest, qualifying in neurology in 1998, taking a PhD in neuroscience in 2002 and qualifying in neuropathology in 2003, and his ORCID record shows him as a clinical physician in the Semmelweis Department of Neurology from October 1994 to December 2002.
• He was a visiting professor or scholar at Indiana University in 2007 and at the University of Pennsylvania in 2016 and 2017.
• He was first author of the 2005 EUROCJD paper on genetic prion disease in Human Genetics 118(2):166-174, published online 15 November 2005, with the Austrian Reference Centre for Human Prion Diseases (OERPE), Vienna as the first author affiliation and 24 named co-authors plus the EUROCJD collective, including Puopolo, Ladogana, Pocchiari, Budka, van Duijn, Collins, Coulthart, Brandel, Zerr, Kretzschmar, de Pedro-Cuesta, Glatzel, Aguzzi, Knight, Will and Mitrova.
• He is the ninth of nineteen authors of the 2021 Lancet Neurology consensus paper on biomarkers and diagnostic guidelines for sporadic CJD (20(3):235-246, PMID 33609480), led from the German national reference centre in Goettingen, in which he is listed with Vienna and Toronto affiliations.
• He is the twenty-sixth of thirty authors of the 2022 Brain paper on the diagnostic accuracy of CSF biomarkers in genetic prion disease, which covered 302 symptomatic cases from eleven diagnostic centres and 36 different PRNP variants, found sensitivity high for E200K and V210I but low for GSS and fatal familial insomnia, and set new genetic prion disease cut-offs for 14-3-3, total tau and alpha-synuclein.
• He is the twenty-fourth of twenty-nine authors of the 2022 Acta Neuropathologica Communications paper describing the sporadic CJD VM1 subtype, first authored by Ellen Gelpi from the Vienna division and OERPE, which reported six cases with codon 129 MV and a mean disease duration of 20.5 months against 3.5 months in MM1 and MV1 cases.
• He is the eighth of twenty-one authors of the 2024 PLoS One genome wide association study of clinical duration and age at onset in sporadic CJD, led from the MRC Prion Unit at UCL, which had duration data for 3,773 cases (median 4 months) and found 53 genome-wide significant SNPs, all on chromosome 20, led by rs1799990.
• He is the ninth of forty authors of the 2025 Brain multiomic paper on Creutzfeldt-Jakob disease risk genes, led from the VIB Center for Molecular Neurology in Antwerp, which prioritised 32 genes and linked higher STX6 and PDIA4 expression to higher risk and higher MANF protein to protection.
• A Europe PMC author search for Kovacs GG combined with prion or Creutzfeldt returns 156 records, the most recent prion-specific ones being the 2025 Brain risk gene paper and the 2024 duration GWAS; most of his recent output is on tau and alpha-synuclein rather than prion disease.
• A Michael J. Fox Foundation researcher profile states that he has been involved in surveillance of human prion diseases since 1994 and names human prion diseases and alpha-synucleinopathies as his research interests.
• The Laboratory Medicine and Pathobiology page lists the 2025 Richard G. Hegele Award for Excellence in Research and Innovation.
• His profiles describe him as editor of books on neuropathology and co-editor of the textbook Greenfield's Neuropathology, but the publication figures are inconsistent and none of the pages is dated: more than 280 papers with h-index 48, more than 380 with h-index 62 and more than 390 with h-index 72.
• An ORCID name search returns one record, 0000-0003-3841-5511, that lists both Vienna and Toronto institutions, which is how the two career halves were tied to one person.

Timeline

1. 1994Started as clinical physician in the Department of Neurology, Semmelweis University, Budapest.
2. 1998Qualified in neurology at Semmelweis University.
3. 2000Began a neuropathology residency at the Institute of Neurology, Medical University of Vienna, running to June 2002.
4. 2002Completed a PhD in neuroscience at Semmelweis University.
5. 2003Qualified in neuropathology at Semmelweis University.
6. 2003ORCID record dates the start of his post as head of neuropathology at the National Institute of Psychiatry and Neurology, Budapest; Toronto profiles date it 2004.
7. 2005EUROCJD genetic prion disease paper published online with him as first author from the Austrian reference centre in Vienna.
8. 2007Started as associate professor at the Institute of Neurology, Medical University of Vienna.
9. 2011Took over leadership of the Austrian Reference Centre for Human Prion Diseases.
10. 2019Vienna appointment ended, and with it his leadership of both reference centres.
11. 2019All four Toronto appointments began.
12. 2021Lancet Neurology consensus on sporadic CJD biomarkers and diagnostic criteria published with him as a co-author listed from Vienna and Toronto.
13. 2022Brain paper on CSF biomarker accuracy in genetic prion disease published.
14. 2022Sporadic CJD VM1 subtype paper published online.
15. 2024Sporadic CJD duration and age at onset GWAS published.
16. 2025Richard G. Hegele Award for Excellence in Research and Innovation.
17. 2025Brain multiomic CJD risk gene paper published.